Search for Clinical Trial Results
Neoplasms, Fibrous Tissue - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets Condition: Desmoid Type-fibromatosis Date: 2015-01-28 Interventions: Drug: Toremifene Patients will receive 60 mg daily and then 180 daily in case of progression |
Active, not recruiting |
Study Name: Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis Condition: Desmoid-Type Fibromatosis Date: 2014-02-17 Interventions:
|
Recruiting |
Study Name: Peripheral Primitive Fibromatosis Condition: Peripheral Primitive Fibromatosis Date: 2013-02-25 Interventions: Other: MRI MRI every 3 months during the first year and then every 6 months during the second year and t |
Recruiting |
Study Name: A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis Condition: Desmoid Tumor Date: 2010-12-06 Interventions: Drug: Sirolimus
|
Withdrawn |
Study Name: Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors Condition:
Date: 2009-09-15 Interventions: Drug: Hydroxyurea Patients will take oral hydroxyurea with a starting dose of 20 mg/kg daily. Patients w |
Completed |
Study Name: Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis Condition: Desmoid Tumor Date: 2006-02-06 Interventions: Drug: imatinib mesylate |
Completed |
Study Name: Radiation Therapy in Treating Patients With Aggressive Fibromatoses Condition: Desmoid Tumor Date: 2002-02-14 Interventions: Radiation: radiation therapy |
Completed |
Study Name: Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery Condition:
Date: 2007-03-20 Interventions:
|
Completed |
Study Name: Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma Condition:
Date: 2006-06-07 Interventions:
|
Completed |
Study Name: Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans Condition:
|